Evolus Inc (EOLS NASDAQ) stock market data APIs
$6.2944
0.18(2.9%)
as of May 6, 2026
Try our APIs with
free plan!
Evolus Inc Financial Data Overview
Price chart is built with
Anychart
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Prev. Close
6.2944
Open
6.4714
High
6.7479
Low
6.2096
52 wk Range
3.86-10.62
Market Cap
416 M
Shares Outstanding
65 855 K
Revenue
302 M
EPS
-0.0495
Beta
1.287
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Evolus Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Evolus Inc data using free add-ons & libraries
Get Evolus Inc Fundamental Data
Evolus Inc Fundamental data includes:
- Net Revenue: 302 M
- EBITDA: -23 152 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-05-12
- EPS/Forecast: -0.1206
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Evolus Inc News
New
Evolus, Inc. Q1 2026 Earnings Call Summary
Evolus, Inc. Q1 2026 Earnings Call Summary - Moby Strategic Execution and Operational Context Achieved a second consecutive quarter of positive adjusted EBITDA during a seasonally low revenue period...
Evolus, Inc. (EOLS) Reports Q1 Loss, Tops Revenue Estimates
Evolus, Inc. (EOLS) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to a loss of $0.18 per share a year ago. These figures are ad...
April 2026's Leading Growth Stocks With Insider Confidence
The United States market has shown robust performance, rising 3.4% over the last week and an impressive 35% over the past year, with earnings expected to grow by 16% annually. In such a thriving envir...
Revance CEO Nadeem Moiz on Expansion, Opportunities & Capitalization
By Karen Roman Exec Edge sat down with Nadeem Moiz, Chief Executive Officer at Revance, to learn more about the company’s vision in aesthetics, skincare and therapeutics. Exec Edge: Tell us about ...
Get Evolus Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
